Interaction of antibacterial compounds with RND efflux pumps in Pseudomonas aeruginosa
Jürg Dreier1, Paolo Ruggerone2
1Basilea Pharmaceutica International Ltd., Basel, Switzerland.
Abstract:
Pseudomonas aeruginosa infections are becoming increasingly difficult to treat due to intrinsic antibiotic resistance and the propensity of this pathogen to accumulate diverse resistance mechanisms. Hyperexpression of efflux pumps of the Resistance-Nodulation-Cell Division (RND)-type multidrug efflux pumps (e.g., MexAB-OprM), chromosomally encoded by mexAB-oprM, mexCD-oprJ, mexEF-oprN, and mexXY (-oprA) is often detected in clinical isolates and contributes to worrying multi-drug resistance phenotypes. Not all antibiotics are affected to the same extent by the aforementioned RND efflux pumps. The impact of efflux on antibiotic activity varies not only between different classes of antibiotics but also between members of the same family of antibiotics. Subtle differences in physicochemical features of compound-pump and compound-solvent interactions largely determine how compounds are affected by efflux activity. The combination of different high-resolution techniques helps to gain insight into the functioning of these molecular machineries. This review discusses substrate recognition patterns based on experimental evidence and computer simulations with a focus on MexB, the pump subunit of the main RND transporter in P. aeruginosa.
Insights
Pseudomonas aeruginosa exhibits multidrug resistance due to efflux pumps like MexAB-OprM. Understanding how these pumps affect antibiotic activity is crucial for developing new treatments against challenging infections.
Area of Science:
- Microbiology
- Biochemistry
- Pharmacology
Background:
- Pseudomonas aeruginosa infections are increasingly difficult to treat due to antibiotic resistance.
- Multidrug resistance is often mediated by the hyperexpression of Resistance-Nodulation-Cell Division (RND)-type multidrug efflux pumps.
- Specific efflux pumps, such as MexAB-OprM, MexCD-OprJ, MexEF-OprN, and MexXY-OprA, are frequently detected in clinical isolates.
Purpose of the Study:
- To review substrate recognition patterns of RND-type multidrug efflux pumps in Pseudomonas aeruginosa.
- To elucidate the impact of efflux on antibiotic activity, considering variations between antibiotic classes and individual compounds.
- To focus on the MexB subunit of the primary RND transporter in P. aeruginosa.
Main Methods:
- Review of experimental evidence regarding efflux pump substrate recognition.
- Analysis of computer simulations to understand compound-pump and compound-solvent interactions.
- High-resolution techniques to gain insight into the functioning of these molecular machineries.
Main Results:
- The impact of efflux pumps on antibiotic activity varies significantly, even among antibiotics within the same class.
- Physicochemical properties of antibiotic-pump interactions are key determinants of efflux pump substrate specificity.
- MexB, a subunit of the main RND transporter, plays a critical role in substrate recognition.
Conclusions:
- Understanding efflux pump substrate recognition is vital for overcoming multidrug resistance in P. aeruginosa.
- Targeting specific efflux pump mechanisms, like those involving MexB, could lead to more effective antimicrobial strategies.
- Further research combining experimental and computational approaches is needed to fully understand these complex systems.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Gene Regulation in Microbial Communities: Quorum Sensing
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis


